Search Within

Christopher A Famulare

Formats
  1. Meeting Abstract (49)
  2. Journal Article (32)
  3. Research Letter (7)
Groups
  1. Center for Hematologic Malignancies (88)
  2. Department of Medicine (85)
  3. Hematologic Malignancies, Division of (85)
  4. Adult Leukemia (83)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (56)
  6. GSK Faculty (56)

More Groups

People
  1. Ross Levine (48)
  2. Martin Tallman (39)
  3. Aaron Goldberg (37)
  4. Eytan Stein (30)
  5. Mikhail Roshal (28)
  6. Minal Patel (27)

More People

Years
  1. 2025 (5)
  2. 2024 (4)
  3. 2023 (10)
  4. 2022 (4)
  5. 2021 (11)
  6. 2020 (14)

More Years

Publications
  1. Blood (49)
  2. Blood Advances (6)
  3. American Journal of Hematology (4)
  4. Cancer Discovery (4)
  5. Leukemia and Lymphoma (3)
  6. Laboratory Investigation (2)

More Publications

Publishers
  1. American Society of Hematology (55)
  2. Nature Publishing Group (10)
  3. American Association for Cancer Research (5)
  4. John Wiley & Sons, Inc. (4)
  5. Taylor & Francis Group (3)
  6. Cell Press (2)

More Publishers

Results (88)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • m(6)A regulates differentiation state and mRNA translation in myeloid leukemia
    Meeting Abstract

    Vu, L. P.; Pickering, B. F.; Cheng, Y.; Sara, Z.; Nguyen, D.; Minuesa, G.; Chou, T.; Chow, A.; MacKay, M.; Famulare, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • SETBP1 and NRAS mutations are frequent events in post-myeloproliferative neoplasm acute myeloid leukemia (post-MPN AML) lacking JAK-STAT activating mutations
    Meeting Abstract

    Menghrajani, K.; Rapaport, F.; McNamara, C. J.; Devlin, S. M.; Famulare, C.; Patel, M.; Medina, J.; Sandy, L.; Kosiorek, H.; Singer Weinberg, R.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Clinical and pathological features of B-cell acute lymphoblastic leukemia following maintenance treatment with lenalidomide for multiple myeloma
    Meeting Abstract

    Geyer, M. B.; Shaffer, B. C.; Landau, H.; Hassoun, H.; Famulare, C.; Roshal, M.; Dogan, A.; Arcila, M. E.; Park, J. H.
    Blood (2017)

    Fulltext@MSK | Save
  • Molecular profiling in extramedullary acute myeloid leukemia reveals distinct subgroups defined by mutations in KIT and RUNX1
    Meeting Abstract

    Goldberg, A. D.; Farnoud, N.; Goldberger, C.; Patel, M.; Famulare, C.; Medina, J.; Rampal, R. K.; Levine, R. L.; Berman, E.; Zhang, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells
    Journal Article

    Vu, L. P.; Pickering, B. F.; Cheng, Y.; Zaccara, S.; Nguyen, D.; Minuesa, G.; Chou, T.; Chow, A.; Saletore, Y.; MacKay, M.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • The genomic landscape of leukemic transformation of myeloproliferative neoplasm
    Meeting Abstract

    Menghrajani, K.; Rapaport, F.; Famulare, C.; Patel, M.; Manshouri, T.; Verstovsek, S.; Levine, R.; Rampal, R.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells
    Journal Article

    Vu, L. P.; Prieto, C.; Amin, E. M.; Chhangawala, S.; Krivtsov, A.; Calvo-Vidal, M. N.; Chou, T.; Chow, A.; Minuesa, G.; Park, S. M.; more...
    Nature Genetics (2017)

    Fulltext@MSK | Save
  • MSI2 is required for maintaining activated myelodysplastic syndrome stem cells
    Journal Article

    Taggart, J.; Ho, T. C.; Amin, E.; Xu, H.; Barlowe, T. S.; Perez, A. R.; Durham, B. H.; Tivnan, P.; Okabe, R.; Chow, A.; more...
    Nature Communications (2016)

    Fulltext@MSK | Save